Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04883099
Other study ID # LEN101
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 6, 2021
Est. completion date October 31, 2021

Study information

Verified date January 2022
Source Lentechs, LLC
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Vision and comfort, both objective and subjective, will be assessed for single vision contact lens wearers for either the APIOC™ for Presbyopia or the APIOC™ for Presbyopia Astigmatism contact lenses.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date October 31, 2021
Est. primary completion date October 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria: 1. The subject must provide written informed consent. 2. The subject must appear willing and able to adhere to the instructions set forth in this protocol. 3. At least 40 years of age and no more than 70 years of age. 4. = 4.00 D of corneal astigmatism. 5. = 2.50 D of refractive astigmatism. 6. Refractive error range +4.00 DS to -6.00 DS 7. Require a reading addition (bifocal) of at least 0.75 D 8. Flat and steep keratometry readings within 40 to 48 D. 9. Clear, healthy corneas with no irregular astigmatism. 10. Normal, healthy conjunctiva in both eyes. 11. Free of active ocular disease. Refractive error and presbyopia are permitted. 12. Be a current or former (within the last 3 years) contact lens wearer. 13. Best-corrected near and distance visual acuity better than or equal to 20/25. Exclusion Criteria: 1. Irregular corneal astigmatism. 2. Corneal scarring unless off line-of-site and well healed. 3. Pinguecula, pterygium, or other conjunctival thickness abnormalities that would interfere with soft contact lens wear. 4. Recent use of any ocular pharmaceutical treatments, including daily artificial tears, in the two weeks prior to the examination. Occasional artificial tear use is permitted. 5. Systemic disease that would interfere with contact lens wear. 6. Currently pregnant or lactating (by self-report). 7. History of strabismus or eye movement disorder, including exophoria at near that is 4 D or greater than at far, and a receded near point of convergence break that is 6 cm or greater. 8. Active allergies that may inhibit contact lens wear. 9. Upper eyelid margin at or above the superior limbus. 10. History of ocular or lid surgery. 11. Immediate family members or significant others of doctors or staff at the clinical site.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
APIOC for Presbyopia and APIOC for Presbyopia for Astigmatism
Contact Lenses for Presbyopia

Locations

Country Name City State
United States Gaddie Eye Centers Lexington Kentucky
United States Miamisburg Vision Care Miamisburg Ohio
United States Vision Professionals New Albany Ohio
United States Eola Eyes Orlando Florida
United States Eyecare Professionals of Powell Powell Ohio
United States Complete Family Vision Care San Diego California

Sponsors (1)

Lead Sponsor Collaborator
Lentechs, LLC

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Acuity Distance High and Low Contrast LogMAR Day 7
Primary Subjective Vision Quality Visual analogue scale (0-100 points) 100 is best possible quality of vision Day 7
Primary Comfort Visual analogue scale(0-100 points) 100 is best possible comfort Day 7
Primary Visual Acuity Near High and Low Contrast Day 7
Primary Visual Acuity Intermediate High and Low Contrast Day 7
Secondary Subjective Comfort Compared to habitual lenses, rated as better/same/worse Day 7
Secondary Subjective vision Comparison Compared to habitual lenses, rated as better/same/worse Day 7
See also
  Status Clinical Trial Phase
Recruiting NCT04923841 - Myopia Control Using Bright Light Therapy, Myopic Defocus and Atropine N/A
Active, not recruiting NCT04080128 - Examination of Myopia Progression and Soft Bifocal Contact Lens Myopia Control N/A
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Completed NCT04604405 - Effects of 650nm Low Energy Light on Human Retina and Choroid Microcirculation N/A
Recruiting NCT05594719 - The Effect of Sun-like Spectrum With Different Spectrum Composition on Retinal Blood Flow N/A
Completed NCT05594732 - The Effects of Different Outdoor Light Exposure Modes on Retinal Blood Flow N/A
Completed NCT04492397 - Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI) N/A
Completed NCT04536571 - Vision Stability and Preference for Soft Toric vs. Soft Spherical Contact Lenses N/A
Completed NCT06046209 - Comparing a Monthly Replacement Lens Versus a Daily Disposable Lens N/A
Recruiting NCT06344572 - Pivotal Study of SAT-001 in Treatment of Pediatric Patient With Myopia Phase 3
Recruiting NCT05611294 - Contralateral Study of Topography Guided LASIK Versus Small Incision Lenticule Extraction N/A
Completed NCT05656885 - Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses N/A
Active, not recruiting NCT05534022 - Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression. N/A
Completed NCT03934788 - the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT03701516 - Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding Process 2 N/A
Completed NCT05538754 - Post-Market Evaluation of the EVO ICL N/A
Completed NCT03139201 - Clinical Performance of the OxyAqua Daily Disposable Silicone Hydrogel Soft Contact Lens N/A
Completed NCT02555722 - Evaluation of the CooperVision, Inc. Fanfilcon A and Enfilcon A Daily Wear Contact Lenses When Used for Frequent Replacement for up to One (1) Month of Daily Wear N/A
Not yet recruiting NCT06009458 - Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear N/A
Recruiting NCT05548478 - Corneal Endothelial Cell Injury Induced by Mitomycin-C N/A